This Solicitation opportunity from Department Of Defense was posted on August 9, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

SUCRALFATE TABLETS

Closed

SPE2DP-26-T-4579Federal

Submission Closed08/17/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

Supply of Electrical Insulation Tape (NSN 5970-01-012-4280)This subcontract involves the supply of electrical insulation tape, identified by NSN 5970-01-012-4280, for prime contractors working on DLA Weapons Support ASC projects. The contractor is required to provide two rolls of tape delivered FOB Origin to Evenes Airbase. All materials must strictly conform to technical specification BASIC CID A-A-59474D, Revision D, and adhere to MIL-STD-2073-1E and RP001 for packaging and MIL-STD-129 for marking. To be eligible, the supplier must hold either SAE AS9003 or ISO 9001 certification and maintain full compliance with DFARS 252.204-7012. This procurement is managed by the Department of Defense under the DLA Weapons Support ASC Supplier Oper AE and AF Div, with a response deadline set for November 5, 2026.

DLA WEAPONS SUPPORT ASC SUPPLIER OPER AE AND AF DIV

POSTED

DEADLINE

Sterile X-Ray Detectable Packing Gauze SupplierThis subcontract involves the supply of 640 units of sterile, medical-grade packing gauze for prime contractors supporting Department of Defense medical supply contracts. The required product is a 1-ply, soft, white Z-fold gauze measuring 3 inches by 5 yards, featuring an embedded X-ray detectable line. To ensure clinical safety and longevity, the gauze must be sterilized to medical standards to maintain a shelf life of 60 months. The contract is managed under the Medical Supply Chain MD Surg FSF and requires strict adherence to the Berry Amendment and the Buy American Act for NSN 6510-01-695-5824. Performance for this requirement is centered in San Diego, California. Interested parties must note the response deadline of November 3, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Tolnaftate Powder (USP 1%)This subcontract involves the supply of Tolnaftate Powder, USP 1%, to prime contractors supporting the Department of Defense Medical Supply Chain Pharm FSA. The requirement specifies the delivery of two bottles of pharmaceutical product, with each unit consisting of a 45 GM sealed container. All supplies must strictly adhere to United States Pharmacopeia standards and utilize commercial packaging and packing methods to ensure the integrity of the contents. The opportunity is categorized under NAICS code 325412 and is associated with a performance location in FPO 96678. Interested parties must note the response deadline of November 3, 2026, following the posting date of October 28, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supplier of Disposable PVP Iodine ApplicatorsThis subcontract involves the supply of individually packaged disposable PVP Iodine swab sticks to prime contractors supporting Department of Defense medical supply contracts through DLA Troop Support. The required product must match NSN 6515-01-519-2226, utilizing medical-grade Povidone-Iodine solution and medical-grade packaging. Each delivery unit consists of packages containing 50 applicators. Strict quality and timing standards are mandated, requiring a minimum shelf life of 15 months and delivery within two months of the date of manufacture. The contract is categorized under NAICS code 325412 and is managed by the Medical Supply Chain MD Surg FSF. Performance for this requirement is designated for FPO 09592-4700.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Calcium Carbonate Chewable TabletsThis subcontract involves the supply of regular strength, peppermint-flavored calcium carbonate chewable tablets for prime contractors supporting the Department of Defense via the Medical Supply Chain Pharm FSA. The requirement specifies 500 MG tablets provided in bottles of 150 count, with a total delivery of 10 bottles. All products must adhere to a non-extendable shelf life of 36 months under Type I, Code Q specifications. The provider must maintain pharmaceutical manufacturing qualifications and ensure full FDA compliance for over-the-counter medications. Performance for this contract is designated for Fort Stewart, Georgia. Interested parties must respond by November 3, 2026, in accordance with the solicitation guidelines.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Lidocaine Hydrochloride and Dextrose Injection ManufacturerThis subcontract involves the manufacture and supply of sterile, nonpyrogenic Lidocaine Hydrochloride and Dextrose Injection to support prime contractors fulfilling Department of Defense supply contracts through the Medical Supply Chain Pharm FSA. The production process requires compounding 2g of Lidocaine Hydrochloride USP and 5g of Hydrous Dextrose USP with Water for Injection USP to achieve a 500 ML bag fill volume. All manufacturing must occur in sterile compounding environments using containers that are latex-free, DEHP-free, and PVC-free to ensure full compliance with USP standards and FDA requirements. The performance of this contract is based in Williamsburg, Virginia, under NAICS code 325412. The scope of work concludes with the delivery of finished sterile injection bags. Interested parties should note the response deadline of November 3, 2026, for this specific procurement opportunity.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Chlorine Dioxide Water Purification TabletsThis subcontract involves the supply of stabilized chlorine dioxide water purification tablets for prime contractors supporting Department of Defense projects under the DLA Troop Support Medical Supply Chain. The required tablets must contain no active chlorine or iodine and be delivered in units of 10 individually sealed tablets per package. To ensure operational readiness, the product must maintain a 60-month shelf life and adhere strictly to Medical Marking Standard No. 1 and MIL-STD-2073-1E. The scope of work requires the delivery of 10 packages of tablets on a FOB Destination basis. The project is categorized under NAICS code 325412 and is managed by the Medical Supply Chain Pharm FSA. Performance for this contract is designated for APO 96319-5024.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Electrical Insulation Tape (NSN 5970010124280)This subcontract involves the supply of electrical insulation tape to prime contractors supporting Defense Logistics Agency Weapons Support aviation supply contracts. The requirement is for two rolls of tape in 36-yard units that strictly adhere to NSN 5970010124280 specifications. The contractor must ensure rigorous quality control and logistics compliance, performing sampling according to MIL-STD-1916 or ASQ H1331 Table 1. Additionally, all materials must be packaged and marked in accordance with MIL-STD-2073-1E, RP001, and MIL-STD-129 standards. This opportunity falls under NAICS code 325412 and is managed by the Department of Defense.

Defense Logistics Agency

POSTED

DEADLINE

Supplier of Multi-Parameter Urine Test Strips and Color ChartsThis subcontract opportunity is for the supply of multi-parameter urine test strips and corresponding color charts to support prime contractors on DLA Troop Support Medical Supply Chain projects for the Department of Defense. The required medical-grade strips must be capable of analyzing bilirubin, blood, glucose, ketone, leukocytes, nitrite, pH, protein, specific gravity, and urobilinogen. All products must strictly adhere to Regulation 862.1340 Class II and Medical Marking Standard No. 1, and must be delivered in bottles of 100 strips with a minimum shelf life of 18 months. The procurement falls under NAICS code 325412 and is managed by the Medical Supply Chain MD SURG FSF. The place of performance is designated as FPO 09592-4700. Interested parties should note the posted date of October 28, 2026, with a response deadline set for November 3, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Salicylic Acid Plaster SupplierThis subcontract involves the manufacture and supply of Salicylic Acid Plasters for prime contractors serving the Department of Defense Medical Supply Chain. The required plasters must measure 5.08 cm by 7.62 cm, feature a flannel back, and consist of a composition of 40 percent salicylic acid and 60 percent base. Each order must be packaged in units of 25 and maintain a minimum shelf life of 24 months. The supplier is responsible for delivering items under NSN 6510011202643 while ensuring full compliance with MIL-STD-129 and DFARS 252.225-7001 standards. Performance for this contract is designated for FPO 09592-4700, with the procurement falling under NAICS code 325412.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Salicylic Acid Gel SupplierThis subcontract involves the supply of 17 percent concentration Salicylic Acid Gel in 7 gram tubes for prime contractors supporting Department of Defense projects under the DLA Troop Support Medical Supply Chain. The supplier is responsible for manufacturing or sourcing the gel to exact concentration specifications and ensuring all packaging meets MIL-STD-2073-1E and RP001 medical-grade tubing standards. Additionally, the provider must adhere to Medical Marking Standard No. 1 and maintain Medical Controlled Room Temperature throughout the transport process. The contract is categorized under NAICS code 325412 and requires the delivery of the finished pharmaceutical product FOB Destination. Performance for this requirement is centered at Fort George G Meade. Interested parties must note the response deadline of November 3, 2026, for this medical supply chain procurement.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Isopropyl Alcohol (99% Isopropanol) SupplierThis subcontract involves the sourcing and manufacture of medical-grade 99 percent Isopropyl Alcohol to support prime contractors for the Department of Defense Medical Supply Chain Pharm FSA. The supplier is responsible for ensuring that all isopropanol meets USP Over-the-Counter standards and is produced using USP grade chemical materials within compliant bottling facilities. Key deliverables include the provision of the alcohol in bottles along with Safety Data Sheets for approval by the contracting officer. The performance of this contract is centered in FPO 96672, with a response deadline set for November 3, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 10 hours ago

DEADLINE

in 6 days

AI Contract Overview

Sucralfate tablets, each containing 1 gram of the active ingredient, are procured in bottles of 100 tablets, with a total order quantity of six bottles, under solicitation SPE2DP-26-T-4579. The contract requires strict adherence to FDA-regulated pharmaceutical standards and mandates a minimum of 31 months of remaining shelf life at the time of receipt, with a total shelf life of 36 months that is non-extendable. Storage must be maintained at 20 to 25°C (68 to 77°F) with protection from light and moisture. All packaging must conform to commercial standards as specified in the DLA packaging requirements, with each unit sealed in a protective container and shipped in commercial exterior containers suitable for safe delivery by common carrier at the lowest cost to Fort Bragg, North Carolina. Packaging and labeling must comply with Medical Marking Standard No. 1A dated February 4, 2013, which supersedes MIL-STD-129, and palletization must follow RP001 guidelines. Hazardous material handling is governed by FED-STD-313 and TQ requirement IP025 if applicable, otherwise ASTM D3951 applies, though DLA’s Master List of Technical and Quality Requirements takes precedence. The product is designated RX ONLY and must be accompanied by a submitted Safety Data Sheet prior to award, or the offeror will be deemed nonresponsible. Delivery is required within 20 days of order acknowledgment, with FOB Destination terms, and shipment must occur via the fastest traceable means, excluding parcel post. The contract references multiple DFARS and FAR clauses governing cybersecurity, safeguarding covered defense information, prohibition of certain foreign equipment, combating trafficking in persons, hazardous material identification, and compliance with NIST SP 800-171 assessment requirements. Contractors must register in DLA’s AMPS system to access VSM and are required to validate representations in SAM. The solicitation is processed through DIBBS with a submission deadline of August 17, 2026, and payment must be submitted electronically via Wide Area Workflow. The procurement may be awarded automatically unless first article test requirements are present, and the HUBZone price evaluation preference applies unless waived. All suppliers must comply with Buy American and Berry Amendment provisions, with a reduced threshold of $150,000, and disclose any non-domestic content. The approved

General Info

Six bottles of 1g sucralfate tablets, 31-month shelf life, 20-25°C storage, DLA packaging, shipped to Fort Bragg within 20 days.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

BLD A5474 PRATT ST, FORT BRAGG, NC, 28310, USA

Set-Aside

NONE

Documents

RFQ SPE2DP-26-T-4579 Medical Supply Chain Pharma FSA

rfq

High

AI Contract Breakdown

Uniform Contract Format

Timeline

PhaseClosed

PostedAug 9

Solicitation

Response DeadlineAug 17

Deadline has passed

Submission Closed

08/17/2026, 05:00:00 PM UTC

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Contacts1 person available

OfficeUSA

Organization / AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Office AddressUSA

Contacts

Patrell Postell

contact@example.gov

Full Description

SUCRALFATE TABLETS
SUCRALFATE TABLETS
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO contact@example.gov. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
.
RX ONLY
.
TABLETS FOR ORAL ADMINISTRATION
.
ACTIVE INGREDIENTS: 1 GRAM SUCRALFATE
.
UNIT OF ISSUE IS A BOTTLE CONTAINING
100 TABLETS
SPE2DP-26-T-4579
SECTION B
.
TOTAL SHELF LIFE IS 36 MONTHS.
.
THERE SHALL BE A MINIMUM OF 31 MONTHS
OF REMAINING SHELF LIFE AT THE TIME
OF RECEIPT BY THE FIRST GOVERNMENT ACTIVITY.
.
STORE AT 20 TO 25°C (68 TO 77°F)
PROTECT FROM LIGHT AND MOISTURE.
.
LABELING AND MARKING MUST IN ACCORDANCE WITH
MEDICAL MARKING STANDARD NO. 1A DATED 4 FEBRUARY 2013.
.
04/13/2015
.
1 BT = 100 TT
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
TEVA PHARMACEUTICALS USA, INC. 3V8D7 P/N NDC00093-2210-01 AMERISOURCEBERGEN DRUG CORP 1XUY5 P/N NDC00591-0780-01 GREENSTONE LLC 48KC0 P/N NDC59762-0401-01 CHARTWELL RX LLC 8APG0 P/N NDC62135-0436-41
TDP Rev A Gen 1 IAW REFERENCE REVISION NR DTD PART PIECE NUMBER:
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017766208 0001 BT 6.000
NSN/MATERIAL:6505011230984
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
SPE2DP-26-T-4579
SECTION B
PR: 7017766208 PRLI: 0001 CONT’D
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
BULK BREAK POINT:
W50YF2
0051 MD CO MEDICAL LOGISTI
AWCF SSF
BLD A5474 PRATT ST
FORT BRAGG NC 28310
US
SHIP BY FASTEST TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
W50YF2
0051 MD CO MEDICAL LOGISTI
AWCF SSF
BLD A5474 PRATT ST
FORT BRAGG NC 28310
US
MARKFOR
W50YF2
0051 MD CO MEDICAL LOGISTI
AWCF SSF
BLD A5474 PRATT ST
FORT BRAGG NC 28310
US
M/F: (TCN) W50YF262160033
RDD: 230
PROJ: TP 2
SUPP ADD: W9046W SIG: C
FOR GOVERNMENT USE ONLY: (IPD) 05
DIC: A0A DIST: V ADV: 2A FC: Z9
Need Ship Date:00/00/0000 Original Required Delivery Date:08/10/2026
SPE2DP-26-T-4579 NSN/Part Number: 6505-01-123-0984 Quantity: 6 BT Purchase Request: 7017766208QTY: 6 Delivery: 20 days ADO